IL6 and Stroke: We found that per SD (4.26 pg/mL) increase in IL‐6 concentration was associated with a significantly 19% increased risk of stroke recurrence (aOR, 1.19; 95% CI, 1.09–1.29) and a significantly 22% increased risk of disability (aOR, 1.22; 95% CI, 1.15–1.30) at 90 days (Table 2).